Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Updated Outcome from Biomarker MSC-C5b-9-Guided All-Trans Retinoic Acid Treatment for Resistant/Recurrent ITP: A Multicenter, Randomized, Open-Label, Phase 3 Clinical Trial

Menglin Li, HaiXia Fu, Hui Liu, Ru Feng, Yi Liu, Jingwen Wang, Lei Yang, Zhao Wang, Gaochao Zhang, Qingyuan Qu, Yuxiu Chen, Jianying Zhou, Mengyu Xiao, Lulu Wang, Mengtong Zang, Yun He, Xiaolu Zhu, Xiaosu Zhao, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 712.

https://doi.org/10.1182/blood-2024-198335

Published: 2024

Journal Articles

Evaluation of the Real-World Efficacy of Hetrombopag for the Treatment of Thrombocytopenia Post Allogeneic Hematopoietic Stem Cell Transplantation

Rui MA, Xueyi Luo, Wei Sun, Wei Han, Yun He, Yu Wang, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Xiao Jun Huang, Yuqian Sun

Blood (2024) 144 (Supplement 1): 2160.

https://doi.org/10.1182/blood-2024-200535

Published: 2024

Journal Articles

Effects of Low-Molecular-Weight Heparin on Pregnancy Outcomes in Protein S Deficiency: A Prospective, Randomized Controlled Phase II Clinical

Mengtong Zang, HaiXia Fu, Yuxiu Chen, Menglin Li, Jianying Zhou, Mengyu Xiao, Lulu Wang, Zhuo-Yu An, Xiaolu Zhu, Yun He, Chen-Cong Wang, KaiYan Liu, LanPing Xu, Xiao Jun Huang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 300.

https://doi.org/10.1182/blood-2024-204674

Published: 2024

Journal Articles

Comparison of Two Conditioning Regimens for Haploidentical Stem Cell Transplantation in Patients with Severe Aplastic Anemia

Fan Lin, Lanping Xu, Zhengli Xu, Ting-Ting Han, Yun He, Yuan-Yuan Zhang, Yi-Fei Cheng, Xiao-Dong Mo, Jingzhi Wang, Yu Wang, Xiaohui Zhang, Xiaojun Huang

Blood (2024) 144 (Supplement 1): 3511.

https://doi.org/10.1182/blood-2024-208246

Published: 2024

Journal Articles

Letermovir for Prevention of Cytomegalovirus Infection in Chinese Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Phase 3, Open-Label, Single-Arm Trial

Yun He, Lanping Xu, Yujun Dong, Xianmin Song, Yicheng Zhang, Erlie Jiang, Hu Yu, Ren Lin, Ying Wang, Xiaodan Guo, Weiwei Zhao, Cyrus Badshah

Blood (2024) 144 (Supplement 1): 7302.

https://doi.org/10.1182/blood-2024-199269

Published: 2024

Journal Articles

Outcome for Mothers and Neonates Among Pregnant Women with Von Willebrand Disease: A Prospective Nationwide Multicenter Study

Qiusha Huang, Xiaolu Zhu, Yun He, HaiXia Fu, Qi Chen, Peng Zhao, Jin Wu, YingJun Chang, LanPing Xu, Xue Xu, Xiaohong Zhang, Jianliu Wang, Xiaojun Huang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 3703.

https://doi.org/10.1182/blood-2024-205168

Published: 2024

Journal Articles

Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Menglin Li, Yi-Meng Li, Qingyuan Qu, Yuxiu Chen, Jianying Zhou, Mengyu Xiao, Chencong Wang, Qi Chen, Xiaolu Zhu, Yun He, YuanYuan Zhang, Qian Jiang, Hao Jiang, Jin Lu, YingJun Chang, Xiaosu Zhao, Xiangyu Zhao, Xiao Jun Huang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 1486.

https://doi.org/10.1182/blood-2024-204777

Published: 2024

Journal Articles

The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy

Yun He, Haixia Fu, Xiaolu Zhu, Qiusha Huang, Qi Chen, Jin Wu, Yuxiu Chen, Peng Zhao, Kai-Yan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 1213.

https://doi.org/10.1182/blood-2023-185453

Published: 2023

Journal Articles

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Blood (2023) 142 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2023-184415

Published: 2023

Journal Articles

The Combination of Iguratimod and Danazol Versus Danazol As a Treatment of Corticosteroid-Resistant/Relapse Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-Label Trial

Xiaolu Zhu, Hui Liu, Zhao Wang, Zhongxing Jiang, Liangming Ma, Min Wang, Jiamin Zhang, Zhuoyu An, Yejun Wu, Yun He, Haixia Fu, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiao Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2589.

https://doi.org/10.1182/blood-2023-184342

Published: 2023

Journal Articles

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Zhuo-Yu An, Yun He, Xiao-lu Zhu, Qiu-Sha Huang, Jin Wu, Haixia Fu, Yuan-Yuan Zhang, Ying-jun Chang, Xiangyu Zhao, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2582.

https://doi.org/10.1182/blood-2023-188139

Published: 2023

Journal Articles

Evaluation of ISTH Severe Bleeding Criteria and Development of a Mortality Prognosis Model for Hospitalized Immune Thrombocytopenia Patients: A Multicenter, Retrospective and Prospective Cohort Study

Zhuo-Yu An, Haixia Fu, Yun He, Xiaolu Zhu, Jin Wu, Qiu-Sha Huang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2580.

https://doi.org/10.1182/blood-2023-187920

Published: 2023

Journal Articles

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

Song Wang, Yan Zhu, Xiaolu Zhu, Haixia Fu, Yun He, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Chenhua Yan, Yuhong Chen, Xiangyu Zhao, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2154.

https://doi.org/10.1182/blood-2023-184380

Published: 2023

Journal Articles

Projected Global Trends in Hematological Malignancies: Incidence, Mortality, and Disability-Adjusted Life Years from 2020 to 2030

Zhuo-Yu An, Haixia Fu, Yun He, Xiaolu Zhu, Qiu-Sha Huang, Jin Wu, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3810.

https://doi.org/10.1182/blood-2023-187856

Published: 2023

Journal Articles

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Menglin Li, Haixia Fu, Yi Liu, Hui Liu, Ru Feng, Zhao Wang, Jingwen Wang, Yuxiu Chen, Qingyuan Qu, Mengyu Xiao, Jianying Zhou, Yun He, Xiaolu Zhu, Yuan Kong, Yingjun Chang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3951.

https://doi.org/10.1182/blood-2023-182669

Published: 2023

Journal Articles

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Blood (2023) 142 (Supplement 1): 1207.

https://doi.org/10.1182/blood-2023-181622

Published: 2023

Journal Articles

Eltrombopag Plus Rhtpo for Corticosteroid-Resistant or Relapsed ITP: A Prospective Observed Study

Haixia Fu, Qiusha Huang, Yun He, Chen-Cong Wang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 1217.

https://doi.org/10.1182/blood-2023-186682

Published: 2023

Journal Articles

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Blood (2022) 140 (Supplement 1): 5567–5568.

https://doi.org/10.1182/blood-2022-167362

Published: 2022

Journal Articles

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study

Tim H. Brummendorf, Patrick Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, Stefanie Meyer, Margaret C. Wey, Jamal Saeh, Richard F. Olsson, Arnon P. Kater

Blood (2022) 140 (Supplement 1): 3126–3127.

https://doi.org/10.1182/blood-2022-167203

Published: 2022

Journal Articles

Sitagliptin Alleviates Excessive Autophagy in Macrophages in Immune Thrombocytopenia Patients to Promote Megakaryopoiesis Via the AMPK/mTOR Pathway

Jin Wu, Yun He, Haixia Fu, Qiusha Huang, ZhuoYu An, Ye-Jun Wu, Xiaolu Zhu, Qi Chen, Kaiyan Liu, Xiaohui Zhang

Blood (2022) 140 (Supplement 1): 8618–8619.

https://doi.org/10.1182/blood-2022-165216

Published: 2022

NARROW

Updated Outcome from Biomarker MSC-C5b-9-Guided All-Trans Retinoic Acid Treatment for Resistant/Recurrent ITP: A Multicenter, Randomized, Open-Label, Phase 3 Clinical Trial

Evaluation of the Real-World Efficacy of Hetrombopag for the Treatment of Thrombocytopenia Post Allogeneic Hematopoietic Stem Cell Transplantation

Effects of Low-Molecular-Weight Heparin on Pregnancy Outcomes in Protein S Deficiency: A Prospective, Randomized Controlled Phase II Clinical

Comparison of Two Conditioning Regimens for Haploidentical Stem Cell Transplantation in Patients with Severe Aplastic Anemia

Letermovir for Prevention of Cytomegalovirus Infection in Chinese Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Phase 3, Open-Label, Single-Arm Trial

Outcome for Mothers and Neonates Among Pregnant Women with Von Willebrand Disease: A Prospective Nationwide Multicenter Study

Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

The Combination of Iguratimod and Danazol Versus Danazol As a Treatment of Corticosteroid-Resistant/Relapse Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-Label Trial

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Evaluation of ISTH Severe Bleeding Criteria and Development of a Mortality Prognosis Model for Hospitalized Immune Thrombocytopenia Patients: A Multicenter, Retrospective and Prospective Cohort Study

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

Projected Global Trends in Hematological Malignancies: Incidence, Mortality, and Disability-Adjusted Life Years from 2020 to 2030

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Eltrombopag Plus Rhtpo for Corticosteroid-Resistant or Relapsed ITP: A Prospective Observed Study

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study

Sitagliptin Alleviates Excessive Autophagy in Macrophages in Immune Thrombocytopenia Patients to Promote Megakaryopoiesis Via the AMPK/mTOR Pathway

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only